Jessica Foster, MD

Selected Publications

• Timpanaro A, Song EZ, Toumi R, Elena-Sanchez L, Piccand C, Nemec K, Kordowski A, Lau D, Johnson S, Winter L, Rajendran A, Ronsley R, Oda SK, Gustafson J, Wendler JP, Koschmann C, Evans M, Pattwell S, Jensen MC, Foster JB, Dun MD, Meechan M, Biery MC, Vitanza NA. : Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine glioma. Neuro Oncol. Feb 2026
• Binder ZA, Bagley SJ, Foster JB, O'Rourke DM. : The development of CAR T cells for patients with CNS malignancies. Nat Rev Clin Oncol. 32(2) : 137-150, Feb 2026
• Naqvi AS, Sullivan PJ, Corbett RJ, Sehgal P, Conkrite KL, Rathi KS, Ennis BM, Hayer KE, Zhang B, Brown MA, Miller DP, Sickler A, Kraya AA, Coleman KL, Dybas JM, Geng Z, Blackden C, Arif S, Chroni A, Lahiri A, Hollawell ML, Storm PB, Haydar D, Foster JB, Koptyra M, Madsen PJ, Diskin SJ, Thomas-Tikhonenko A, Resnick AC, Rokita JL. : Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4. Neurooncol Pediatr. Jan 2026
• Pan H, Foster JB, Bosse KR. : Scratching the surface of targeting GPC2 on pediatric CNS tumors. Mol Ther Oncol. 33(4) Dec 2025
• Song EZ, Timpanaro A, Meechan M, Elena-Sanchez L, Li LZ, Jamet S, Lau DS, Winter LI, Dun MD, Foster JB, Evans MK, Pattwell SS, Kalia V, Sarkar S, Jensen MC, Biery MC, Vitanza NA. : Engineered CXCR3-A expression enhances B7-H3-targeting CAR T cell migration and efficacy against diffuse intrinsic pontine glioma. Nat Commun. 16(1) Nov 2025
• Madsen PJ, Schlitter AM, Flemmig C, Dickson C, Harvey K, Wilson C, Beaubien E, Patterson L, Stern A, Griffin C, Joshi N, Hajeebu S, Martinez D, Storm PB, Resnick AC, Hillemanns P, Stanulla M, Faber J, Wingerter A, Gaida MM, Holtemeyer S, Laible M, Feldner A, Frohns F, Duarte JH, Sinn BV, Wöll S, Sahin U, Türeci Ö, Foster JB. : Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors. J Immunother Cancer. 13(10) Oct 2025
• Fathi Kazerooni A, Kraya A, Rathi KS, Kim MC, Kesherwani V, Corbett R, Vossough A, Khalili N, Gandhi D, Khalili N, Familiar AM, Jin R, Huang X, Zhu Y, Sickler A, Lueder MR, Phul S, Storm PB, Ware JB, Foster JB, Mueller S, Rokita JL, Fisher MJ, Resnick AC, Nabavizadeh A. : Imaging Clusters of Pediatric Low-Grade Glioma Are Associated with Distinct Molecular Characteristics. AJNR Am J Neuroradiol. 46(8) : 1716-1725, Aug 2025
• Mikkelsen MK, Li X, Yu K, High AA, Tan H, Furtado LV, Leelatian N, Bell J, Berry JD, Boué DR, Chien F, Coven SL, Dewan MC, Fangusaro J, Foster JB, Hoffman L, Kofler JK, Larkin T, Lazow M, May A, Mobley BC, Noun D, Posorske B, Schwartz J, Sheila I, Spiller S, Tanaka R, Qaddoumi I, Tinkle CL, Peng J, Robinson GW, Moreira DC, Chiang J. : Diffuse leptomeningeal glioneuronal tumor (DLGNT): a comprehensive clinical and molecular analysis. Acta Neuropathol. 150(1) : 18, August 2025
• Foster JB, Madsen PJ, Harvey K, Griffin C, Stern A, Patterson L, Joshi N, Dickson C, McManus O, Beaubien E, Wilson C, Beale DR, Baubet V, Goel P PN, Vitanza NA, Nazarian J, Koptyra M, Storm PB, Resnick AC. : Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models. Neuro Oncol. May 2025
• Timpanaro A, Song EZ, Amwas N, Chiu CH, Ronsley R, Taylor MR, Foster JB, Wang LD, Vitanza NA. : Evolving CAR T-Cell Therapy to Overcome the Barriers in Treating Pediatric Central Nervous System Tumors. Cancer Discov. 15(5) : 890-902, May 2025